Major Left Bundle Branch Block and Coronary Heart Disease-Are There Any Differences between the Sexes?
Diana GurzăuAlexandra Dădârlat-PopBogdan CaloianGabriel CismaruHoraţiu ComşaRaluca TomoaiaDumitru ZdrengheaDana PopPublished in: Journal of clinical medicine (2021)
Left bundle branch block is not a benign pathology, and its presence requires the identification of a pathological substrate, such as ischemic heart disease. Left bundle branch block appears to be more commonly associated with normal coronary arteries, especially in women. The objectives of our study were to describe the particularities of left bundle branch block in women compared to men with ischemic heart disease. Result: We included seventy patients with left bundle branch block and ischemic heart disease, with a mean age of 67.01 ± 8.89 years. There were no differences in the profile of risk factors, except for smoking and uric acid. The ventricular depolarization (QRS) duration was longer in men than women (136.86 ± 8.32 vs. 132.57 ± 9.19 msec; p = 0.018) and also men were observed to have larger left ventricular diameters. Left bundle branch block duration was directly associated with ventricular diameters and indirectly associated with left ventricular ejection fraction value, especially in women (R = -0.52, p = 0.0012 vs. R = -0.50, p = 0.002). In angiography, 80% of women had normal epicardial arteries compared with 65.7% of men; all these patients presented with microvascular dysfunction. Conclusion: The differences between the sexes were not so obvious in terms of the presence of risk factors; instead, there were differences in electrocardiographic, echocardiographic, and angiographic aspects. Left bundle branch block appears to be a marker of microvascular angina and systolic dysfunction, especially in women.
Keyphrases
- left ventricular
- ejection fraction
- polycystic ovary syndrome
- aortic stenosis
- risk factors
- heart failure
- pregnancy outcomes
- uric acid
- cervical cancer screening
- coronary artery disease
- cardiac resynchronization therapy
- breast cancer risk
- coronary artery
- middle aged
- metabolic syndrome
- end stage renal disease
- acute myocardial infarction
- chronic kidney disease
- oxidative stress
- hypertrophic cardiomyopathy
- smoking cessation
- pulmonary hypertension
- insulin resistance
- optical coherence tomography
- skeletal muscle
- aortic valve